Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale
Go back to Federal Court Enters Judgment Confirming RA Capital and Avilar Therapeutics Willfully and Maliciously Misappropriated Trade Secret Developed at Yale, Formalizing $4 Million Award to Biohaven and Yale| (NYSE: BHVN) | Delayed: 14.72 -0.97 (6.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $15.69 | 52 Week High | $ | |||
| Open | $14.91 | 52 Week Low | $ | |||
| Day High | $15.80 | P/E | N/A | |||
| Day Low | $14.33 | EPS | $ | |||
| Volume | 3,306,272 | |||||
